Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics

Current Opinion in Pediatrics

Volumn 17, Issue 1, 2005, Pages 67-70

  Buescher, E Stephen ^a,b  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b NONE   (United States)

Author keywords

Community acquired; Methicillin; Resistance; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; LEUKOCIDIN; LINCOSAMIDE; MACROLIDE; PENICILLIN BINDING PROTEIN 2A; RIFAMPICIN; STREPTOGRAMIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CLINICAL FEATURE; COMMUNICABLE DISEASE; GENE CASSETTE; GENETIC CODE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CHILD; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 12744254893     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000147906.30720.4d     Document Type: Review

References (25)

1. Holden MTG, Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004; 101:9786-9791. Molecular analysis of S. aureus genomes that emphasizes genetic plasticity of this organism.
2. Robinson DA, Enright MC: Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:3926-3934. Model of S. aureus evolution that illustrates repetitive emergence of MRSA.
3. Seal JB, Moreira B, Bethel CD, et al. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15 year longitudinal assessment in a large University-based hospital. Infect Contr Hosp Epidemiol 2003; 24:403-408.
4. Mongkolrattanothai K, Boyle S, Kahana MD, et al. Severe Staphylococcus aureus infections caused by clonally-related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003; 37:1050-1058. Illustrates molecular relatedness of CA-MRSA and MSSA from the same communities.
5. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 98:978-984. Demonstrates high frequency of PVL carriage by CA-MRSA.
6. Lim TT, Chong FN, O'Brien FG, et al. Are all community methicillin-resistant Staphylococcus related? A comparison of their mec regions. Pathology 2003; 35:336-343.
7. Pan ES, Diep BA, Carleton HA, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infections in California jails. Clin Infect Dis 2003; 37:1384-1388. Illustrates rapid increases in frequency of CA-MRSA as cause of disease.
8. Hussain FM, Boyle-Vavra S, Berthel CD, et al. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000; 19:1163-1166.
9. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J 2004; 23:619-624. Illustrates rapid emergence of CA-MRSA in a pediatric hospital environment.
10. Sattler CA, Mason EO, Kaplan SL: Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21:910-917.
11. Centers for Disease Control: Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:793-795.
12. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701-706. Discusses CA-MRSA musculoskeletal infections, their treatment, and responses to therapy.
13. Tseng MH, Lin WJ, Teng CS, et al. Primary sternal osteomyelitis due to community-acquired methicillin-resistant Staphylococcus aureus: case report and literature review. Online Eur J Pediatr [serial online] Aug 6, 2004.
14. Frank AL, Marcinak JF, Mangat PD, et al. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999; 18:993-1000.
15. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001; 33:990-996.
16. Schlievert PM, Della-Latta P: Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among post-partum women. Clin Infect Dis 2003; 37:1313-1319. Illustrates risks and results of nosocomial CA-MRSA spread.
17. Centers for Disease Control: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota. MMWR Morb Mortal Wkly Rep 1999; 48:707-710.
18. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23:123-127. Documents resolution of localized CA-MRSA infections after incision and drainage, without effective antibiotic treatment.
19. Martinez-Aguilar G, Hammerman WA, Mason EO, et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistance and methiciuin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003; 22:593-598. Illustrates good responses of CA-MRSA infections to clindamycin treatment.
20. Drinkovic D, Fuller ER, Shore KP, et al. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001; 48:315-329.
21. Siberry GK, Tekle T, Carroll K, et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37:1257-1260. Case report of CA-MRSA clindamycin treatment failure caused by inducible clindamycin resistance.
22. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21:530-534.
23. Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth Informational Supplement. NCCLS, M100-S14, V24, No. 1, 2004. Documents method for performing and interpreting D-test.
24. Schreckenberger PC, Ilendo E, Ristow KL: Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42:2777-2779.
25. Boyce JM, Havill NL, Kohan C, et al. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2004; 25:395-401. Discusses infection control measures for MRSA and why they are difficult to achieve.